Am. J. Respir. Crit. Care Med., Vol 151, No. 2, 02 1995, 406-411.
Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability
PL Enright, JE Connett, RE Kanner, LR Johnson and WW Lee
Respiratory Sciences Center, University of Arizona, Tucson.
The Lung Health Study (LHS) is a randomized clinical trial designed to
determine whether a smoking intervention program and use of an inhaled
bronchodilator (BD) can reduce the rate of decline of FEV1 in cigarette
smokers with airflow limitation. During recruitment, spirometry was
performed at second and third screening visits, a mean of 21 d apart. A
total of 5,887 smokers, 35 to 60 yr of age and of whom 63% were men, met
the study eligibility requirements. Smokers taking physician- prescribed
BDs or with an FEV1 < 50% or > 90% predicted were excluded, as were
those whose FEV1/FVC ratio was greater than 70%. Two inhalations of
isoproterenol were given to determine BD response during the second visit.
A serial dilution methacholine challenge test was done during the third
visit to determine nonspecific airway reactivity. Ninety-five percent of
the differences between FEV1 measured at the two visits were within 240 ml
for women and within 320 ml for men (coefficients of repeatability). The
best independent predictors of the mean short-term (between visit)
intraindividual FEV1 variability were factors indicating intrinsic airway
reactivity of the participants: bronchodilator response, methacholine
reactivity, and the presence of wheezing; as well as factors influenced by
the quality of spirometry testing: the difference between the highest and
second highest FEV1s and peak flows during baseline spirometry, and the
time to reach peak flow (PEFT).
This article has been cited by other articles:

|
 |

|
 |
 
E. Hnizdo, K. Sircar, T. Yan, P. Harber, J. Fleming, and H. W Glindmeyer
Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals
Occup. Environ. Med.,
October 1, 2007;
64(10):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. McCormack, D. Shade, and R. A. Wise
Spirometer Calibration Checks: Is 3.5% Good Enough?
Chest,
May 1, 2007;
131(5):
1486 - 1493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Herpel, R. E. Kanner, S. M. Lee, H. E. Fessler, F. C. Sciurba, J. E. Connett, R. A. Wise, and for the Lung Health Study Research Group and the N
Variability of Spirometry in Chronic Obstructive Pulmonary Disease: Results from Two Clinical Trials
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1106 - 1113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zanconato, G. Meneghelli, R. Braga, F. Zacchello, E. Baraldi, and on behalf of the Working Group
Office Spirometry in Primary Care Pediatrics: A Pilot Study
Pediatrics,
December 1, 2005;
116(6):
e792 - e797.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Hnizdo, L Yu, L Freyder, M Attfield, J Lefante, and H W Glindmeyer
The precision of longitudinal lung function measurements: monitoring and interpretation
Occup. Environ. Med.,
October 1, 2005;
62(10):
695 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med.,
October 1, 2003;
168(7):
818 - 900.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T R Schermer, J E Jacobs, N H Chavannes, J Hartman, H T Folgering, B J Bottema, and C van Weel
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD)
Thorax,
October 1, 2003;
58(10):
861 - 866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Sanders, A. B. Newman, C. L. Haggerty, S. Redline, M. Lebowitz, J. Samet, G. T. O'Connor, N. M. Punjabi, and E. Shahar
Sleep and Sleep-disordered Breathing in Adults with Predominantly Mild Obstructive Airway Disease
Am. J. Respir. Crit. Care Med.,
January 1, 2003;
167(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Decramer, P.N.R. Dekhuijzen, T. Troosters, C. van Herwaarden, M. Rutten-van Molken, C.P.O. van Schayck, D. Olivieri, I. Lankhorst, and A. Ardia
The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design
Eur. Respir. J.,
March 1, 2001;
17(3):
329 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eaton, S. Withy, J. E. Garrett, J. Mercer, R. M. L. Whitlock, and H. H. Rea
Spirometry in Primary Care Practice: The Importance of Quality Assurance and the Impact of Spirometry Workshops
Chest,
August 1, 1999;
116(2):
416 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|